Current stock page

Stock Analysis

Insulet Corp. (PODD) Stock Analysis

Insulet Corp. (PODD) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

PODD Stock Analysis Summary

Insulet Corp. (PODD) currently has an AIQ Score of 66/100, indicating a neutral setup. Quality is the strongest factor at 77/100. Value is the weakest current factor at 45/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Oct 30, 2026 · Market-close data

PODD at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$149.68
AIQ Score66/100
Overall ViewNeutral
Technical Analysis ConsensusStrong Buy
Market Cap$10.28B
P/E Ratio (TTM)27.68
Forward P/E—
EPS (quarter ended 2026-06-30)$1.37
Revenue (quarter ended 2026-06-30)$801.7M
Dividend Yield (TTM)0.00%
Beta1.1
Volume1.09M
52-week range$126.40-$354.88
RSI 1476.69
50-Day SMA$140.86
200-Day SMA$179.46
Analyst Price Target$203.32
Next EarningsNov 4, 2026
As of Oct 30, 2026 · Market close

PODDInsulet Corp.

Healthcare / Medical - Devices

Leader

Strong Relative Position

NeutralEdge 9/10
$149.68−$2.82 (−1.85%)

Latest quote

  • Momentum
    77
  • Value
    45
  • Quality
    77
  • Risk resilience
    69
  • Sentiment
    —
algovestiq.comScore data as of Oct 30, 2026

PODD Stock Analysis Summary

Insulet Corp. (PODD) currently has an AIQ Score of 66/100, indicating a neutral setup. Quality is the strongest factor at 77/100. Value is the weakest current factor at 45/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Oct 30, 2026 · Market-close data
AIQ Composite Posture: Mixed

In a neutral regime, PODD has AIQ Score of 66/100 with Quality base of 77/100 and fading Value at 45/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Quality (77/100) leads while Value (45/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · -1.85% stock move · PODD classified in Medical - Devices.

Current Evidence

NeutralPODD is in a neutral AIQ regime; Quality is the strongest visible factor at 77/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is PODD Bullish or Bearish Right Now?

PODD currently has a neutral overall setup. Momentum is the strongest factor at 77/100, while Value is weakest at 45/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.

Bull Case
  • - Quality is supportive at 77/100.
  • - Momentum is constructive at 77/100.
  • - Risk Resilience is supportive at 69/100.
  • - Price is +8.27% above its 50-day SMA.
  • - Analyst target implies +35.84% upside from the latest quote.
Bear Case
  • - Price is -15.02% below its 200-day SMA.

Current Consensus

PODD's Technical Analysis Consensus is currently Strong Buy, with 34 buy, 2 neutral, and 9 sell votes. PODD's 14-day RSI is 76.69, which places the stock in an overbought momentum range. PODD's beta is 1.1, indicating market sensitivity broadly in line with the market.

Signal Confidence
High agreement

What Changed in PODD?

The largest recent change in PODD is Risk Resilience moving up by 2.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.

AIQ Score
+0.0
Momentum
+0.0
Quality
+0.0
Risk
+2.0

What Would Change the PODD Outlook?

The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

PODD Decision Framework

Public evidence layers, setup checks, and risk context for Insulet Corp..

Insulet Corp. (PODD) Stock Analysis

Insulet Corp. has an AIQ Score of 66/100 in a Neutral regime. Momentum is strongest at 77/100. Beta is 1.1, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextPODD is in a Neutral AIQ regime with score 66/100.
Signal ConflictThe primary conflict is that momentum leads at 77/100 while value lags at 45/100.
Factor EvidenceMomentum 77/100 · Value 45/100 · Quality 77/100 · Risk 69/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Momentum is the strongest factor at 77/100.

TimingPass

Momentum is 77/100 and RSI (14) is 76.7.

Regime fitPass

PODD is in a Neutral regime at 66/100.

Risk controlPass

Risk factor is 69/100 with beta 1.1 and annual volatility 45.07%.

ConflictWait

Current conflict: momentum leads at 77/100 while value lags at 45/100.

AIQ Score
66/100
Price
$149.68
Beta
1.1
RSI (14)
76.7

PODD Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

PODD Fundamentals

PODD valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$801.7M
Net income
$95M
Free cash flow
$59.4M
View full PODD fundamental analysis

PODD Technical Analysis

PODD technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Buy
RSI 14
76.69
Price vs SMA-50
+8.27%
View full PODD technical analysis

PODD Stock Catalysts

Track PODD earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Nov 4, 2026
Analyst target
$203.32
News items
0
View PODD earnings and stock catalysts

PODD Dividend Analysis

PODD dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
0.00%
View PODD dividend history and analysis

PODD Financial Data

PODD revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$801.7M
EPS
$1.37
Periods
4
View PODD financials

PODD Risk Analysis

PODD volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
1.1
Risk score
69/100
1Y volatility
45.07%
View PODD risk analysis

PODD Stock News

PODD stock news, market tone, recent headlines, and catalyst context.

News items
0
Updated
—
Sentiment
—
Read PODD stock news

PODD vs Medical Devices Peers

Current peer cohort: PODD · RMD · SOLV · STE · SYK. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
PODD
Current stock
66/10045/10077/10069/100-1.4745.07%Current
RMD
ResMed
68/10042/10082/10076/100028.80%PODD vs RMD
SOLV
Solventum
58/10067/10038/10054/1000.6229.98%PODD vs SOLV
STE
Steris
63/10048/10083/10071/100-0.126.00%PODD vs STE
SYK
Stryker
62/10042/10080/10064/100-0.5430.40%PODD vs SYK
Pairwise Compare links: RMD · SOLV · STE · SYKPODD vs RMDPODD vs SOLVPODD vs STEPODD vs SYKCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Oct 30, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a PODD stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

4 recent quarterly periods are available for review.

Checked Oct 31, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
27.68
As of Oct 29, 2026
Revenue growth
—
Gross margin
71.08%
Current debt / equity
0.67
Latest quarterly evidence

Latest period Jun 30, 2026.

Review fundamentals
Quarter revenue
$801.7M
Quarter net income
$95M
Quarter free cash flow
$59.4M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Mixed
Momentum
Bullish
RSI 14
76.69
MACD
3.16

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
69/100
Beta
1.1
Annual volatility
45.07%
Max drawdown
-62.33%

PODD Stock FAQ

What is PODD stock price today?

Insulet Corp.'s current stock price is $149.68. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is PODD bullish or bearish right now?

PODD's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is PODD's market cap?

PODD's market cap is $10.28B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is PODD's current P/E ratio?

PODD's current P/E ratio is 27.68 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is PODD's RSI?

PODD's 14-day RSI is 76.69 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is PODD above its 50-day and 200-day moving averages?

PODD is 8.27% from its 50-day SMA and -15.02% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is PODD's next earnings date?

PODD's next earnings date is currently listed as Nov 4, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does PODD pay a dividend?

PODD's dividend yield is 0.00% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.